Max Healthcare Institute Ltd vs Sharma East India Hosp And Medical Research Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 24, 2026

Key Highlights

The Latest Trading Price of Max Healthcare Institute Ltd is ₹ 817 as of 23 Oct 15:30 . The P/E Ratio of Max Healthcare Institute Ltd changed from 55.6 on March 2022 to 64.9 on March 2026 . This represents a CAGR of 3.14% over 5 yearsThe P/E Ratio of Sharma East India Hosp and Medical Research Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 years The Market Cap of Max Healthcare Institute Ltd changed from ₹ 19903 crore on March 2021 to ₹ 93581 crore on March 2026 . This represents a CAGR of 29.43% over 6 yearsThe Market Cap of Sharma East India Hosp and Medical Research Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 years The revenue of Max Healthcare Institute Ltd for the Jun '26 is ₹ 2406 crore as compare to the Mar '26 revenue of ₹ 2190 crore. This represent the growth of 9.86% The revenue of Sharma East India Hosp and Medical Research Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Max Healthcare Institute Ltd for the Jun '26 is ₹ 638.97 crore as compare to the Mar '26 ebitda of ₹ 654.26 crore. This represent the decline of -2.34% The ebitda of Sharma East India Hosp and Medical Research Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Max Healthcare Institute Ltd changed from ₹ 236.27 crore to ₹ 322.96 crore over 9 quarters. This represents a CAGR of 14.90% The net profit of Sharma East India Hosp and Medical Research Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The Dividend Payout of Max Healthcare Institute Ltd changed from 13.98 % on March 2023 to 27.16 % on March 2026 . This represents a CAGR of 18.06% over 4 yearsThe Dividend Payout of Sharma East India Hosp and Medical Research Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Max Healthcare Institute Ltd

Max Healthcare Institute Limited was originally incorporated as 'Infinitum Technologies Private Limited' at New Delhi, India as a Private Limited Company dated June 18 ,2001.
Pursuant to a Fresh Certificate of Incorporation dated June 28, 2002, the name of Infinitum Technologies Private Limited' was changed to Max Healthcare Institute Private Limited'.
Thereafter, pursuant to a Special Resolution dated May 16, 2002 and a fresh Certificate of Incorporation dated October 18, 2002, the Company converted to a Public Limited, and name was changed to Max Healthcare Institute Limited'.
The Company is primarily engaged in provision of healthcare services through primary care clinics, multi speciality hospitals / medical centres and superspecialty Hospitals facilities. The Company is a leading hospital chains in India with major concentration in North India consisting of a network of 22 network healthcare facilities, which includes BLK Hospital and BNH Hospital.

About Sharma East India Hosp and Medical Research Ltd

Sharma East India Hospitals & Medical Research Limited was incorporated on November 16, 1989.
The Company is engaged in providing medical and healthcare services and real estate services and is presently running a multi-specialty hospital in the name of 'Jaipur Hospital' at Lal Kothi, at Rajasthan since 1989. As far as the achievements of the Company are concerned, the first assessment of the Company was conducted by National Accreditation Board for Hospitals and Health Care Providers (NABH), NABH accreditation system is one of the methods for commitment to quality enhancement throughout whole of the health care system in India.
It involves all professional and service groups to ensure that high quality in health care is achieved, while minimizing the inherent risks associated with modern health care delivery.

FAQs for the comparison of Max Healthcare Institute Ltd and Sharma East India Hosp and Medical Research Ltd

Which company has a larger market capitalization, Max Healthcare Institute Ltd or Sharma East India Hosp and Medical Research Ltd?

Market cap of Max Healthcare Institute Ltd is 79,519 Cr while Market cap of Sharma East India Hosp and Medical Research Ltd is 25 Cr

What are the key factors driving the stock performance of Max Healthcare Institute Ltd and Sharma East India Hosp and Medical Research Ltd?

The stock performance of Max Healthcare Institute Ltd and Sharma East India Hosp and Medical Research Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Max Healthcare Institute Ltd and Sharma East India Hosp and Medical Research Ltd?

As of October 24, 2026, the Max Healthcare Institute Ltd stock price is INR ₹817.0. On the other hand, Sharma East India Hosp and Medical Research Ltd stock price is INR ₹79.15.

How do dividend payouts of Max Healthcare Institute Ltd and Sharma East India Hosp and Medical Research Ltd compare?

To compare the dividend payouts of Max Healthcare Institute Ltd and Sharma East India Hosp and Medical Research Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.